Skip to content

Effect of rajaswalacharya on pain and inflammatory markers in women with primary dysmenorrhea: a randomized controlled trial

Effect of rajaswalacharya in modulating inflamatory marker in udavartini yonivyapad w.s.r. to primary dysmenorrhea - a randomized control trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103280
Enrollment
30
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

None listed

Sponsors

National institute of ayurveda deemed to be university, (de-novo)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female aged 18-30yrs with regular menstrual cycles (24-35day) Patients diagnosed with primary dysmenorrhea based on clinical and laboratory screening. Female complaining of pain during menstruation pain starting 1-2 days before or during menses,lasting 3 days) Pain intensity more than 5 on VAS in at least 3 consecutive cycles. Patient having no h/o any identifiable pelvic pathology (PCOS, endometriosis, fibroids, PID etc.)

Exclusion criteria

Exclusion criteria: Female diagnosed with secondary dysmenorrhea such as pcos, endometriosis,adenomyosis, leiomyoma and pid etc Known case of chronic inflammatory disorders(eg h/o any T.B, R.A, S.L.E,Hypothyroidism etc. Known case of Malignancy of any part of the body. Known case of Positive cases of HIV, VDRL, HBsAG and HCV Patient taking Hormonal contraceptive since last 6month. Patient having Severe anemia Patients with congenital anomaly of reproductive tract Patient with h/o fever past 2 months

Design outcomes

Primary

MeasureTime frame
Changes in inflammatory marker level i.e. IL6, conducted through blood tests before and after treatment.Timepoint: 2 months

Secondary

MeasureTime frame
Changes in VAS pain score, Reduction in severity of menstrual symptoms, Improvement in quality of life on SF36 Questionnaire Timepoint: 2 months

Countries

India

Contacts

Public ContactNeetu narolia

National institute of ayurveda of deemed to be university, (de-novo),

nn20212024@gmail.com8696244434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026